Table 6—

Performance of the ventilators with the mask having the smallest leak(SOMNOplus; Weinmann, Hamburg, Germany) while the ventilator settings remained those adapted with the recommended masks

ConditionsMeasured parameters
VentilatorPatient profilePS cmH2OIPAP %Δt %tI %VT %Rebreathing % of VTPP %
VPAP III STA UM CfgObstructive disease10100±0.286±998±199±10±0#6±4
15100±0.293±899±1100±0.40±0#3±4
20101±0.178±898±1100±0.310±0.311±4
Restrictive disease10100±2.1#106±3100±2#100±2#8±1-1±2#
15101±0.4106±3107±8106±60±0#-1±1
20101±0.3101±4#99±4#101±3#0±0#1±1
Synchrony 2Obstructive disease10101±0.2140±8109±3107±20±0#-19±2
15100±0.3125±2114±3109±214±2-14±4
20ATATATATATAT
Restrictive disease10100±0.499±2#100±0.5101±0.31±0.20±1
15100±0.3100±2#100±0.5100±0.27±0.30±1
20100±0.4101±11#100±1100±0.312±0.3-1±1
Vivo 40Obstructive disease10114±1.397±14#95±696±60±0#2±2
15113±1.1109±14#105±2111±20±0#-2±0
20116±1.552±898±1115±110±19±0
Restrictive disease10ATATATATATAT
15ATATATATATAT
20ATATATATATAT
  • Data are presented as mean±sd, unless otherwise stated. Values are the percentage of baseline conditions with the recommended mask (table 3), except for rebreathing, which is the percentage of tidal volume (VT), and pressurisation performance (PP), which is the percentage change versus baseline. PS: pressure support; IPAP: inspiratory positive airway pressure measured; Δt: time from inspiration onset to airway pressure above positive end-expiratory pressure; tI: inspiratory time; VT: tidal volume; rebreathing: percentage of expired volume remaining in the device circuit at the end of expiration; PP: pressurisation performance; AT: auto-triggering. VPAP III STA UM Cfg: ResMed, Saint Priest, France; Synchrony 2: Respironics, Nantes, Fracne); Vivo 40: Breas, Saint Priest). #: not statistically different from the baseline values.